Heron Therapeutics (HRTX) Other Non-Current Liabilities (2022 - 2026)
Heron Therapeutics' Other Non-Current Liabilities came in at $5.06 million for Q2 2026, up 576.7% from $747,000 a year earlier and up 2.6% from the prior quarter.
Powered by 
Analysis
Heron Therapeutics (HRTX) Other Non-Current Liabilities (2022 - 2026) Analysis & Trends
At the end of FY2025, Heron Therapeutics' Other Non-Current Liabilities was $4.81 million, up 681.8% from FY2024.
- Other Non-Current Liabilities carries a three-year compound annual growth rate of 171.2% (FY2022 to FY2025).
- Going back by year, Other Non-Current Liabilities was $615,000 in FY2024 (+155.2%), $241,000 in FY2023 (unchanged) and $241,000 in FY2022.
- The Q2 2026 figure represents the highest quarterly Other Non-Current Liabilities in data going back to Q1 2022.
- Year-over-year, Other Non-Current Liabilities has increased for three consecutive quarters, with growth averaging 347.1% over the last seven quarters.
- Over the past five years, the year-over-year growth in Other Non-Current Liabilities ranged from 0.0% (Q1 2023) to 681.8% (Q4 2025).
- Business Quant data shows HRTX's Other Non-Current Liabilities at $4.93 million (Q1 2026), $4.81 million (Q4 2025) and $4.69 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Heron Therapeutics | 58.85 Mn | -130.71 Mn | 26.09 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.06 Mn |
| Mar 31, 2026 | 4.93 Mn |
| Dec 31, 2025 | 4.81 Mn |
| Sep 30, 2025 | 4.69 Mn |
| Jun 30, 2025 | 747,000.00 |
| Mar 31, 2025 | 682,000.00 |
| Dec 31, 2024 | 615,000.00 |
| Sep 30, 2024 | 241,000.00 |
| Jun 30, 2024 | 241,000.00 |
| Mar 31, 2024 | 241,000.00 |
| Dec 31, 2023 | 241,000.00 |
| Sep 30, 2023 | 241,000.00 |
| Jun 30, 2023 | 241,000.00 |
| Mar 31, 2023 | 241,000.00 |
| Dec 31, 2022 | 241,000.00 |
| Sep 30, 2022 | 241,000.00 |
| Jun 30, 2022 | 241,000.00 |
| Mar 31, 2022 | 241,000.00 |
API Access
Heron Therapeutics Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=HRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "HRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=HRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();